Undiagnosed OSA increases the risk of high blood pressure

Obstructive Sleep Apnoea (OSA) is a sleep related breathing disorder which occurs if airflow through the nose and mouth is obstructed. Having undiagnosed OSA increases the risk of high blood pressure, and is associated with other serious conditions such as strokes and heart attacks, type II diabetes and depression as well as traffic collisions. OSA affects men, women and children.

A growing amount of evidence suggests that OSA is the most common type of secondary hypertension, however, an estimated 70-90 percent of cases are undiagnosed.

The Meditech apneABP is ideal as an opportunistic outpatient screening tool for OSA and can help diagnose at risk patients prior to referral to specialist sleep labs.

Blood pressure is recorded automatically at pre-set intervals and SP02 data is recorded continuously.

The easy to use CardioVisions software displays 24-hr blood pressure chart, histogram, correlations, blood pressure statistics, oxygen saturation overview, plethysmograph pulse wave, pulse oximetry statistics and activity.

As a result, apneABP gives information not only about blood pressure and general pulse oximetry data, but also about the condition of the arterial system through plethysmograph and pulse wave.

The apneABP e will allow CCGs and GPs to take an active role in OSA screening and referral pathways which is beneficial to the patient, the GP and the sleep clinic.

Author: Andrew Webb

I am the Managing Director of PMS (Instruments) Ltd a successful UK based medical distribution, service and sales company specialising in cardiovascular equipment.